Assessment of Blood Vessel Mimics with Optical Coherence Tomography

Garret T. Bonnema, University of Arizona
Kristen O'Halloran Cardinal, University of Arizona
James B. McNally, University of Arizona
Stuart K. Williams, University of Arizona
Jennifer K. Barton, University of Arizona

Article comments

6 pages.

Copyright © 2007 Society of Photo-Optical Instrumentation Engineers. One print or electronic copy may be made for personal use only. Systematic reproduction and distribution, duplication of any material in this paper for a fee or for commercial purposes, or modification of the content of the paper are prohibited. This paper is also available at http://dx.doi.org/10.1117/1.2718555.

NOTE: At the time of publication, the author Kristen O'Halloran Cardinal was not yet affiliated with Cal Poly.

Abstract

Optical coherence tomography (OCT) is an imaging mo-dality that enables assessment of tissue structural characteristics. Studies have indicated that OCT is a useful method to assess both blood vessel morphology and the response of a vessel to a deployed stent. We evaluated the ability of OCT to visualize the cellular lining of a tissue-engineered blood vessel mimic (BVM) and the response of this lining to a bare metal stent. We develop a side-firing endoscope that obtains intraluminal, longitudinal scans within the sterile bioreactor environment, enabling time-serial assessment. Seventeen BVMs are imaged with the endoscopic OCT system. The BVMs are then evaluated via fluorescence microscopy and/or standard histologic techniques. We determine that (1) the OCT endoscope can be repeatedly inserted without visible damage to the BVM cellular lining, (2) OCT provides a precise measure of cellular lining thickness with good correlation to measurements obtained from histological sections, and (3) OCT is capable of monitoring the accumulation of cellular material in response to a metallic stent. Our studies indicate that OCT is a useful technique for monitoring the BVM cellular lining, and that OCT may facilitate the use of BVMs for early stage device assessment.